Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · Real-Time Price · USD

40.48

-0.52 (-1.27%)

At close: Nov 13, 2026, 4:00 PM EST

39.69

-0.79 (-1.95%)

After-hours: Nov 13, 2026, 7:51 PM EST

Xenon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	82.56	199.16	142.71	148.64	57.24	175.69
Short-Term Investments	868.24	349.72	484.19	489.44	534.85	376.09
Cash & Short-Term Investments	950.8	548.89	626.91	638.08	592.09	551.77
Cash Growth	105.68%	-12.45%	-1.75%	7.77%	7.31%	211.74%
Accounts Receivable	-	-	-	0.87	0.99	2.77
Other Receivables	1.17	1.37	1.47	-	-	-
Receivables	1.17	1.37	1.47	0.87	0.99	2.77
Prepaid Expenses	8.1	10.39	6.89	6.01	7.23	4.48
Total Current Assets	960.07	560.65	635.26	644.96	600.3	559.02
Property, Plant & Equipment	12.52	15.35	18.22	18.85	16.91	12.52
Long-Term Investments	202.68	37.15	127.5	292.79	128.68	-
Long-Term Deferred Tax Assets	15.46	12.86	9.67	0.8	0.51	0.47
Other Long-Term Assets	9.16	7.15	7.5	7.4	7.75	-
Total Assets	1,200	633.16	798.14	964.8	754.15	572.01

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.93	3.89	5.07	8.6	8.49	3.82
Accrued Expenses	42.12	36.06	23.47	17.03	13.38	9.78
Current Portion of Leases	1.15	1.53	1.37	1.3	0.49	0.61
Current Income Taxes Payable	0.11	0.31	5.69	0.35	-	-
Other Current Liabilities	-	-	-	-	0.34	0.12
Total Current Liabilities	45.3	41.79	35.59	27.27	22.7	14.32
Long-Term Leases	4.86	6.41	7.65	9.6	9.95	7.65
Other Long-Term Liabilities	3.33	3.2	-	-	-	-
Total Liabilities	53.49	51.4	43.24	36.88	32.65	21.97

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	2,493	1,599	1,457	1,436	1,065	790.9
Additional Paid-In Capital	227.29	228.23	199.15	156.76	142.11	117.5
Retained Earnings	-1,569	-1,245	-899.47	-665.14	-482.75	-357.37
Comprehensive Income & Other	-5.05	0.34	-1.61	-0.08	-3	-0.99
Shareholders' Equity	1,146	581.76	754.9	927.92	721.5	550.03
Total Liabilities & Equity	1,200	633.16	798.14	964.8	754.15	572.01

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	6.01	7.94	9.02	10.9	10.44	8.26
Net Cash (Debt)	1,147	578.09	745.39	919.97	710.33	543.52
Net Cash Growth	109.80%	-22.44%	-18.98%	29.51%	30.69%	212.94%
Net Cash Per Share	12.51	7.29	9.57	13.75	11.73	12.46
Filing Date Shares Outstanding	98.28	83.19	76.54	75.43	63.04	52.94
Total Common Shares Outstanding	98.28	80.01	76.42	75.37	62.59	52.65
Working Capital	914.76	518.86	599.67	617.69	577.6	544.7
Book Value Per Share	11.67	7.27	9.88	12.31	11.53	10.45
Tangible Book Value	1,146	581.76	754.9	927.92	721.5	550.03
Tangible Book Value Per Share	11.67	7.27	9.88	12.31	11.53	10.45
Machinery	-	14.76	14.38	11.89	11	10.8
Leasehold Improvements	-	9.41	9.36	9.02	4.2	7.02

SEC Filings: 10-K · 10-Q